Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Handling Complaints and Feedback

Posted on By

Standard Operating Procedure for Managing Complaints and Feedback

Purpose

This SOP outlines the procedures for handling complaints and feedback in clinical trials and clinical studies. The goal is to ensure that complaints and feedback from participants, study personnel, and other stakeholders are addressed promptly and effectively to improve study quality and participant experience.

Scope

This SOP applies to all personnel involved in handling complaints and feedback in clinical trials and clinical studies, including principal investigators, clinical research coordinators, study sponsors, and site staff.

Responsibilities

  • Principal Investigator (PI): Ensures complaints and feedback are handled appropriately and takes action on feedback to improve study quality.
  • Clinical Research Coordinators: Assist in managing complaints and feedback, including initial assessment and response.
  • Site Staff: Report complaints and feedback to the study team and assist in addressing participant concerns.
  • Study Sponsors: Provide guidance and support for complaint and feedback management processes.
See also  SOP for Reporting Serious Adverse Events (SAEs)

Procedure

  • Receipt of Complaints and Feedback:
    • Receive complaints and feedback from participants, study personnel, and other stakeholders through designated channels (e.g., phone, email, in-person).
  • Assessment and Categorization:
    • Assess the nature and severity of complaints and feedback to determine appropriate actions.
    • Categorize complaints and feedback according to study protocols and institutional policies.
  • Response and Resolution:
    • Respond to complaints and feedback promptly, respectfully, and transparently.
    • Resolve complaints and feedback according to established procedures, consulting with relevant parties as needed.
  • Documentation and Record-Keeping:
    • Document complaints and feedback, including the nature, assessment, response, and resolution.
    • Maintain records of complaints and feedback in a secure and organized manner for future reference.
  • Follow-Up and Improvement:
    • Follow up with complainants and those who provided feedback to ensure satisfaction with the resolution.
    • Use feedback and complaints to identify areas for improvement and implement changes as necessary.
See also  SOP for Clinical Trials/Clinical Studies

Abbreviations Used

  • SOP: Standard Operating Procedure
  • PI: Principal Investigator

Documents

  • Records of complaints and feedback
  • Documentation of responses and resolutions

References

  • Institutional policies for handling complaints and feedback
  • Regulatory guidelines for managing complaints and feedback

SOP Version

Version: 1.0

Clinical Studies Tags:Adverse event reporting, Clinical data management, Clinical data validation, Clinical research compliance, Clinical research coordination, Clinical site selection, clinical studies, clinical study, Clinical study protocols, Clinical trial management, Clinical trial monitoring, Clinical trial participants, Clinical trial procedures, Clinical trial SOPs, clinical trials, Conflict of interest management, Data collection methods, Data management SOPs, eCRF validation, Electronic record-keeping guidelines, Electronic systems validation, Ethics committee reporting, Investigator training protocols, Participant data privacy, Participant recruitment strategies, Pharmacovigilance protocols, Quality assurance practices, Regulatory compliance procedures, Risk management procedures, Safety monitoring procedures, Site selection criteria, Study protocol development

Post navigation

Previous Post: SOP for Use of Placebos and Comparator Products
Next Post: SOP for Communication with Sponsors and CROs

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version